Skip to content

Comparison of Positive End Expiratory Pressure Titration Methods in ARDS Patients

Comparison of Positive End Expiratory Pressure Titration Methods in Patients With Acute Respiratory Distress Syndrome: a Physiological Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03281473
Acronym
ELSE
Enrollment
20
Registered
2017-09-13
Start date
2018-10-02
Completion date
2019-12-31
Last updated
2019-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Keywords

ARDS, Esophageal pressure, Mechanical ventilation

Brief summary

This study aims at assessing the short-term physiological effects of 2 positive end expiratory pressure titration strategies in patients with ARDS.

Interventions

OTHERStrategy 1

PEEP titration according to transpulmonary-end-expiratory pressure

OTHERStrategy 2

PEEP titration according to chest wall elastance measurement

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age\> 18 years * Moderate or severe ARDS * Consent to participation obtained from a relative

Exclusion criteria

* Protect adult * Pregnant or breastfeeding woman * No-affiliation to the social security scheme * Contra-indication to the placement of an esophageal pressure measuring catheter * Pneumothorax * Hemodynamic and / or respiratory instability * Extra-corporeal membrane oxygenation

Design outcomes

Primary

MeasureTime frame
Short-term effects of 2 PEEP titration strategies on gas exchange2 hours 15 minutes

Secondary

MeasureTime frame
Short-term effects of 2 PEEP titration strategies on respiratory mechanics2 hours 15 min
Short-term effects of 2 PEEP titration strategies on hemodynamics2 hours 15 min

Countries

France

Contacts

Primary ContactStudy Official is required by the WHO and BELONCLE, Ass.Pr
Francois.Beloncle@chu-angers.fr0241353845

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026